(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

TRATAMENTO DA ASMA COM ANTICORPO ANTI-TSLP

Em ExigênciaInvention PatentPCT · US2018027271

Application data

Number

112019021482

Type

Invention Patent

Filing

04/12/2018

Publication

05/12/2020

PCT

US2018027271

Progress at the INPI

Technical opinion to answer
  1. Filing04/12/18
  2. Publication05/12/20
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The INPI issued a technical opinion on patentability. The applicant must respond for examination to continue.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 08/06/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

AMGEN INC.

US

MEDIMMUNE LLC

US

See this company's full portfolio

Inventors

J. P. (pessoa física)

US

J. G. (pessoa física)

US

Technical data

Priority claims

US

62/484,864 · 04/12/2017

US

62/553,477 · 09/01/2017

US

62/553,575 · 09/01/2017

Abstract

A presente divulgação se refere, em geral, a métodos de tratamento da asma, incluindo asma grave e asma eosinofílica, utilizando um anticorpo específico para linfopoietina do estroma tímica (TSLP).

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Parecer de pré-exame

#6.23

08/06/2024

RPI 2796

Adição na publicação

#15.35

10/19/2021

RPI 2650

Notificação de entrada na fase nacional - PCT

#1.3

05/12/2020

RPI 2575

Alteração de dados cadastrais

#1.1

10/22/2019

RPI 2546

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.